TELA Bio CEO Heather Getz Buys 15,000 Shares

What Happened Heather C. Getz, CEO of TELA Bio, acquired 15,000 shares on August 14, 2026 in an open-market/private purchase (transaction code P). The filing reports a weighted average price of $0.70 per share, for a total reported value of $10,467. This was a purchase (buying) transaction rather than a sale.

Key Details

• Transaction date: 2026-08-14; Filing date: 2026-08-17 (Form 4 accession 0001481485-26-000006).
• Shares bought: 15,000; reported weighted-average price in Column 4: $0.70; total value reported: $10,467.
• Footnote F1: the $0.70 is a weighted average. Actual trade prices ranged from $0.697 to $0.6994; the reporting person will provide a breakdown on request.
• Shares owned after transaction: not specified in the provided filing details.
• No indication in the provided data that this filing was late.

Context Purchases by executives are often watched by investors as one signal of insider confidence, but they are only one data point and do not prove future performance. This was a straightforward open-market purchase (no option exercise, award, or gift involved).